Vance G. Fowler

57.1k total citations · 9 hit papers
400 papers, 31.3k citations indexed

About

Vance G. Fowler is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Vance G. Fowler has authored 400 papers receiving a total of 31.3k indexed citations (citations by other indexed papers that have themselves been cited), including 235 papers in Infectious Diseases, 202 papers in Epidemiology and 114 papers in Clinical Biochemistry. Recurrent topics in Vance G. Fowler's work include Antimicrobial Resistance in Staphylococcus (211 papers), Infective Endocarditis Diagnosis and Management (144 papers) and Bacterial Identification and Susceptibility Testing (114 papers). Vance G. Fowler is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (211 papers), Infective Endocarditis Diagnosis and Management (144 papers) and Bacterial Identification and Susceptibility Testing (114 papers). Vance G. Fowler collaborates with scholars based in United States, Spain and France. Vance G. Fowler's co-authors include Thomas L Holland, Emily M. Eichenberger, Steven Y. C. Tong, Daniel J. Sexton, Joshua S. Davis, Thomas Ryan, G. Ralph Corey, Christopher H. Cabell, Thomas M. Bashore and G. Ralph Corey and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Vance G. Fowler

383 papers receiving 30.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management

2015 3.6k citations Thomas L Holland, Vance G. Fowler et al. profile →
Proposed Modifications to the Duke Criteria for the Diagnosis of Infective Endocarditis

2000 2.9k citations Vance G. Fowler et al. Clinical Infectious Diseases profile →
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications

2015 1.9k citations Vance G. Fowler et al. profile →
Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research

2019 1.4k citations Stacey A. Maskarinec, Thomas L Holland et al. Nature Reviews Microbiology profile →
Infective Endocarditis

2005 1.2k citations Vance G. Fowler et al. profile →
Adverse Clinical and Economic Outcomes Attributable to Methicillin Resistance among Patients withStaphylococcus aureusSurgical Site Infection

2003 723 citations Sara E. Cosgrove, Vance G. Fowler et al. Clinical Infectious Diseases profile →
Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae

2017 479 citations David van Duin, Eric Cober et al. Clinical Infectious Diseases profile →
Clinical Management ofStaphylococcus aureusBacteremia

2014 329 citations Thomas L Holland, Vance G. Fowler et al. profile →
Short- vs Standard-Course Outpatient Antibiotic Therapy for Community-Acquired Pneumonia in Children

2022 80 citations Melinda M. Pettigrew, Vance G. Fowler et al. profile →

Peers

Vance G. Fowler

EPIDE

PHEOH

Arnold S. Bayer United States

Barbara E. Murray United States

William R. Jarvis United States

Emilio Bouza Spain

John G. Bartlett United States

Issam Raad United States

Michael J. Rybak United States

Scott K. Fridkin United States

Larry M. Baddour United States

Allison McGeer Canada

Arnold S. Bayer United States

Vance G. Fowler

16.3k ×1.0

10.6k ×0.7

EPIDE

7.1k ×0.9

PHEOH

5.9k ×0.8

7.5k ×1.3

Citations per year, relative to Vance G. Fowler Vance G. Fowler (= 1×) peers Arnold S. Bayer

Countries citing papers authored by Vance G. Fowler

Since Specialization

Citations

This map shows the geographic impact of Vance G. Fowler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vance G. Fowler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vance G. Fowler more than expected).

Fields of papers citing papers by Vance G. Fowler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vance G. Fowler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vance G. Fowler. The network helps show where Vance G. Fowler may publish in the future.

Co-authorship network of co-authors of Vance G. Fowler

This figure shows the co-authorship network connecting the top 25 collaborators of Vance G. Fowler. A scholar is included among the top collaborators of Vance G. Fowler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vance G. Fowler. Vance G. Fowler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thaden, Joshua T., P. Cox, Sanjay Khandelwal, et al.. (2025). Escherichia coli Type III Secretion System 2 Is Associated With Patient Mortality in Bloodstream Infections. The Journal of Infectious Diseases. 232(5). 1097–1107.

Parsons, Joshua B., Ahmad Mourad, Brian P. Conlon, Tammy Kielian, & Vance G. Fowler. (2025). Methicillin-resistant and susceptible Staphylococcus aureus: tolerance, immune evasion and treatment. Nature Reviews Microbiology. 24(2). 127–145.

Lu, Kuan‐Yi, Rui Sun, B Morris, et al.. (2025). A host-directed adjuvant sensitizes intracellular bacterial persisters to antibiotics. Nature Microbiology. 10(11). 3013–3025. 2 indexed citations

Howard‐Anderson, Jessica, Sarah B. Doernberg, Dennis O. Dixon, et al.. (2025). Interagency Collaboration for Patient-Centered Antibacterial Drug Development. Clinical Infectious Diseases. 81(Supplement_1). S11–S15.

Chambers, Henry F. & Vance G. Fowler. (2024). Intertwining clonality and resistance: Staphylococcus aureus in the antibiotic era. Journal of Clinical Investigation. 134(19). 7 indexed citations

Boutzoukas, Angelique E, Natalie A Mackow, Lauren Komarow, et al.. (2024). Increased mortality in hospital- compared to community-onset carbapenem-resistant enterobacterales infections. Journal of Antimicrobial Chemotherapy. 79(11). 2916–2922. 2 indexed citations

Galloway-Peña, Jessica, David van Duin, Leila Ledbetter, et al.. (2024). Participant Diversity in United States Randomized Controlled Trials of Antibacterials for Staphylococcus aureus Infections, 2000–2021. Clinical Infectious Diseases. 79(1). 141–147. 2 indexed citations

Yasmin, Mohamad, Steven H. Marshall, Liang Chen, et al.. (2024). A molecular analysis of meropenem–vaborbactam non-susceptible KPC-producing Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy. 68(10). e0020824–e0020824.

Jacobs, Michael R., Ayman M. Abdelhamed, Caryn E. Good, et al.. (2024). ARGONAUT-III and -V: susceptibility of carbapenem-resistant Klebsiella pneumoniae and multidrug-resistant Pseudomonas aeruginosa to the bicyclic boronate β-lactamase inhibitor taniborbactam combined with cefepime. Antimicrobial Agents and Chemotherapy. 68(9). e0075124–e0075124. 6 indexed citations

10.

Parsons, Joshua B., Blake Hanson, Felicia Ruffin, et al.. (2024). In-patient evolution of a high-persister Escherichia coli strain with reduced in vivo antibiotic susceptibility. Proceedings of the National Academy of Sciences. 121(3). e2314514121–e2314514121. 15 indexed citations

11.

Iovleva, Alina, Christi L. McElheny, Eric Cober, et al.. (2024). In vitro activity of sulbactam-durlobactam against colistin-resistant and/or cefiderocol-non-susceptible, carbapenem-resistant Acinetobacter baumannii collected in U.S. hospitals. Antimicrobial Agents and Chemotherapy. 68(3). e0125823–e0125823. 15 indexed citations

12.

Dagher, Michael, et al.. (2023). Risk Factors and Outcomes of Hematogenous Vertebral Osteomyelitis in Patients With Staphylococcus aureus Bacteremia. Clinical Infectious Diseases. 77(9). 1226–1233. 12 indexed citations

13.

Wang, Siyu, Stephanie M. Reeve, Graham T. Holt, et al.. (2022). Chiral evasion and stereospecific antifolate resistance in Staphylococcus aureus. PLoS Computational Biology. 18(2). e1009855–e1009855. 6 indexed citations

14.

Beam, Jenna E., Nikki J. Wagner, Edward Moreira Bahnson, et al.. (2021). Macrophage-Produced Peroxynitrite Induces Antibiotic Tolerance and Supersedes Intrinsic Mechanisms of Persister Formation. Infection and Immunity. 89(10). e0028621–e0028621. 25 indexed citations

15.

Fowler, Vance G., Anita Das, Raymond Schuch, et al.. (2020). Exebacase for patients with Staphylococcus aureus bloodstream infection and endocarditis. Journal of Clinical Investigation. 130(7). 3750–3760. 95 indexed citations

16.

Holland, Thomas L, Henry F. Chambers, Helen W. Boucher, et al.. (2018). Considerations for Clinical Trials of Staphylococcus aureus Bloodstream Infection in Adults. Clinical Infectious Diseases. 68(5). 865–872. 30 indexed citations

17.

DebRoy, Sruti, Xiqi Li, Awdhesh Kalia, et al.. (2018). Identification of a chimeric emm gene and novel emm pattern in currently circulating strains of emm4 Group A Streptococcus. Microbial Genomics. 4(11). 13 indexed citations

18.

Galloway-Peña, Jessica, Sruti DebRoy, Xiqi Li, et al.. (2018). Hypervirulent group A Streptococcus emergence in an acaspular background is associated with marked remodeling of the bacterial cell surface. PLoS ONE. 13(12). e0207897–e0207897. 10 indexed citations

19.

Fowler, Vance G.. (2015). Bacteremia and Endocarditis.

20.

Tsalik, Ephraim L., Bradly P. Nicholson, Lynette Waring, et al.. (2009). Multiplex PCR To Diagnose Bloodstream Infections in Patients Admitted from the Emergency Department with Sepsis. Journal of Clinical Microbiology. 48(1). 26–33. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact